Our Introduction
Drug Intermediates
Drug Intermediates are used as raw materials during the manufacture of bulk drugs, in other words pharmaceutical intermediates are chemical compounds which form the building blocks of the active pharmaceutical ingredient (API).
Drug Intermediates can also be referred to as the material produced at the time of synthesis of an active pharmaceutical ingredient (API). Drug intermediates are generally hygienically formulated. Superior grade raw materials are used for their production and these are applied in both the cosmetic and pharmaceutical industries.
| Intermediates | API | CAS |
|---|---|---|
| 3,5-Bis(2-cyano isopropyl) ban alcohol | Anastrozole intermediates | 120511-88-8 |
| 7-Hydroxy-3,4-dihydro-2(1H)-quinolinone | Aripiprazole intermediates | 22246-18-0 |
| (2S,3S)-3-Amino-2-methyl-4-oxo-1-azetidinesulfonic acid | Aztreonam intermediates | 80082-65-1 |
| 3-(4-Chlorophenyl)glutaric acid monoamide | Baclofen intermediates | 1141-23-7 |
| 4-Cyano-3-trifluoromethyl aniline | Bicalutamide intermediates | 654-70-6 |
| 4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine | Bosentan intermediates | 150728-13-5 |
| 3-Bromoacetyl-5-chlorothiophene-2-sulfonamide | Brinzolamide intermediates | 160982-11-6 |
| 2,3,4,6-tetrakis-O-trimethylsilyl-D-gluconolactone | Canagliflozin intermediates | 32384-65-9 |
| 5-(4-Chlorobutyl)-1-cyclohexyl-1H-tetrazole | Cilostazol intermediates | 73963-42-5 |
| D-(+)-Methyl-alpha-(2-thienylethamino)(2-chlorophenyl) acetate HCl | Clopidogrel intermediates | 141109-19-5 |
| N-(4-Cyanophenyl)glycine | Dabigatran intermediates | 42288-26-6 |
| 4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether | Dapagliflozin intermediates | 461432-23-5 |
| 2-Butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran | Dronedarone intermediates | 141645-16-1 |
| (S)-3-(Dimethylamino)-1-(thiophen-2-yl)-propan-1-ol | Duloxetine intermediates | 132335-44-5 |
| 4-Chloro-2-trifluoroacetylaniline HCl hydrate | Efavirenz intermediates | 173676-59-0 |
| 4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine | Eluxadoline intermediates | 623950-02-7 |
| (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy] tetrahydro-furan | Empagliflozin intermediates | 915095-89-5 |